LifeStance Health Gr Stock (NASDAQ: LFST)

LifeStance Health Gr (NASDAQ:LFST) Stock, Quote.Headers.trade-ideas

LifeStance Health Gr

LifeStance Health Group Inc is a mental healthcare company focused on providing evidence-based, medically driven treatment services for children, adolescents, and adults suffering from a variety of mental health issues in an outpatient care setting, both in-person and through its digital health telemedicine offering.

LifeStance Health Group

Earnings

Mid Cap

News

Health Care

Price Target

Markets

Analyst Ratings

Trading Ideas

General

LFST

LifeStance Health Group (NASDAQ: LFST) closed the last trading session at $6.26, gaining 11.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide.

Wall Street Analysts Think LifeStance Health Could Surge 26.68%: Read This Before Placing a Bet

cannabis money (bulkbuddy, PublicDomainPictures by Pixabay)(31)

Cannabis

LFSWF

TSXV:HASH

TSXV:LFST

Lifeist Wellness Inc. (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company reported on Tuesday its financial results for the three months ended May 31, 2024. The Toronto-based company reported a nearly 50% year-over-year drop in net revenue from continued operations to CA$3.9 million ($2.8 million) in the second quarter of fiscal 2024. Meni Morim, CEO of Lifeist said the company&#39;s second-quarter performance &#34;is another clear indication that we must move on from operating our legacy cannabis business segments and find other solutions that have exposure to the broader wellness market.&#34;

LIfeist Shrinks Net Loss: 49% YoY Drop In Q2 Net Revenue, Plans Move Away From Its Legacy Cannabis Business

Shares of LifeStance Health Group (NASDAQ: LFST) have gained 1.3% over the past four weeks to close the last trading session at $5.49, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication.

Wall Street Analysts See a 57.38% Upside in LifeStance Health: Can the Stock Really Move This High?

LifeStance Health Group, Inc. - Common Stock

LifeStance Health Group Inc

<p><a href="https://x.com/MattNachtrab/status/1837188432335888683" title="https://x.com/MattNachtrab/status/1837188432335888683">https://x.com/MattNachtrab/status/1837188432335888683</a></p>


SAVA

UPDATE: Matt Nachtrab Responds To Adam Feuerstein Tweet 'Classic misinformation or FUD spread by the court jester for the short sellers of $sava.  He is the king of manipulation of biotech stocks to benefit short sellers.  Maybe I am disrupting their plans?'

Stock Split

SoFi Approved 1 For 5 Reverse Stock Split For SoFi Select 500 ETF

<p>Financial giants have made a conspicuous bearish move on Moderna. Our analysis of options history for Moderna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) revealed 22 unusual trades.</p>
<p>Delving into the details, we found 31% of traders were bullish, while 54% showed bearish tendencies. Out of all the trades we spotted, 13 were puts, with a value of $4,197,475, and 9 were calls, valued at $516,749.</p>
<h3>What's The Price Target?</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $50.0 to $120.0 for Moderna over the last 3 months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Moderna's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Moderna's whale trades within a strike price range from $50.0 to $120.0 in the last 30 days. </p>
<h3>Moderna Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726863434_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th style="text-align: right;"><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$55.0</td>
<td>$54.25</td>
<td>$54.5</td>
<td>$120.00</td>
<td>$1.3M</td>
<td style="text-align: right;">46</td>
<td style="text-align: right;">752</td>
</tr>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$55.0</td>
<td>$54.75</td>
<td>$55.0</td>
<td>$120.00</td>
<td>$1.0M</td>
<td style="text-align: right;">46</td>
<td style="text-align: right;">952</td>
</tr>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$54.15</td>
<td>$54.1</td>
<td>$54.15</td>
<td>$120.00</td>
<td>$552.3K</td>
<td style="text-align: right;">46</td>
<td style="text-align: right;">102</td>
</tr>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$54.05</td>
<td>$54.0</td>
<td>$54.05</td>
<td>$120.00</td>
<td>$502.6K</td>
<td style="text-align: right;">46</td>
<td style="text-align: right;">272</td>
</tr>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/18/26</td>
<td>$19.05</td>
<td>$16.6</td>
<td>$18.45</td>
<td>$65.00</td>
<td>$276.7K</td>
<td style="text-align: right;">104</td>
<td style="text-align: right;">150</td>
</tr>
</tbody>
</table>
</p>
<h3>About Moderna</h3>
<p>Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.</p>
<p>Having examined the options trading patterns of Moderna, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Current Position of Moderna</h3>
<ul>
<li>Trading volume stands at 12,030,554, with MRNA's price down by -3.43%, positioned at $65.69.</li>
<li>RSI indicators show the stock to be may be oversold.</li>
<li>Earnings announcement expected in 41 days.</li>
</ul>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.</p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Moderna options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Options

MRNA

Moderna Unusual Options Activity For September 20

<p>Financial giants have made a conspicuous bullish move on XPeng. Our analysis of options history for XPeng (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) revealed 8 unusual trades.</p>
<p>Delving into the details, we found 50% of traders were bullish, while 37% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $101,800, and 5 were calls, valued at $879,208.</p>
<h3>Expected Price Movements</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $6.0 to $10.0 for XPeng during the past quarter. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for XPeng's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of XPeng's whale activity within a strike price range from $6.0 to $10.0 in the last 30 days. </p>
<h3>XPeng Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726863429_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>XPEV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$1.82</td>
<td>$1.75</td>
<td>$1.82</td>
<td>$10.00</td>
<td>$387.1K</td>
<td>465</td>
<td>2.1K</td>
</tr>
<tr>
<td>XPEV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$1.88</td>
<td>$1.85</td>
<td>$1.88</td>
<td>$10.00</td>
<td>$363.5K</td>
<td>465</td>
<td>4.0K</td>
</tr>
<tr>
<td>XPEV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$3.85</td>
<td>$3.8</td>
<td>$3.8</td>
<td>$6.00</td>
<td>$53.1K</td>
<td>1.3K</td>
<td>143</td>
</tr>
<tr>
<td>XPEV</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/04/24</td>
<td>$0.15</td>
<td>$0.13</td>
<td>$0.13</td>
<td>$8.50</td>
<td>$39.0K</td>
<td>277</td>
<td>3.1K</td>
</tr>
<tr>
<td>XPEV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$1.91</td>
<td>$1.89</td>
<td>$1.89</td>
<td>$10.00</td>
<td>$37.8K</td>
<td>465</td>
<td>4.5K</td>
</tr>
</tbody>
</table>
</p>
<h3>About XPeng</h3>
<p>Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 141,000 EVs in 2023, accounting for about 2% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.</p>
<p>Following our analysis of the options activities associated with XPeng, we pivot to a closer look at the company's own performance.</p>
<h3>Where Is XPeng Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 12,013,899, the XPEV's price is up by 2.13%, now at $9.59. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 54 days.</li>
</ul>
<h3>Expert Opinions on XPeng</h3>
<p>1 market experts have recently issued ratings for this stock, with a consensus target price of $11.5.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Showing optimism, an analyst from JP Morgan upgrades its rating to Overweight with a revised price target of $11. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for XPeng with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


XPEV

XPeng's Options Frenzy: What You Need to Know

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Workday</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with WDAY, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 13 uncommon options trades for Workday.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 76% bullish and 7%, bearish.</p>
<p>Out of all of the special options we uncovered, 3 are puts, for a total amount of $112,330, and 10 are calls, for a total amount of $1,420,928.</p>
<h3>Expected Price Movements</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $240.0 to $250.0 for Workday over the recent three months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of Workday stands at 683.5, with a total volume reaching 5,349.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Workday, situated within the strike price corridor from $240.0 to $250.0, throughout the last 30 days.</p>
<h3>Workday Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726863424_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th style="text-align: right;"><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>WDAY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$15.9</td>
<td>$15.6</td>
<td>$15.73</td>
<td>$250.00</td>
<td>$225.6K</td>
<td style="text-align: right;">753</td>
<td style="text-align: right;">673</td>
</tr>
<tr>
<td>WDAY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$15.8</td>
<td>$15.7</td>
<td>$15.87</td>
<td>$250.00</td>
<td>$223.3K</td>
<td style="text-align: right;">753</td>
<td style="text-align: right;">882</td>
</tr>
<tr>
<td>WDAY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$16.1</td>
<td>$15.6</td>
<td>$15.85</td>
<td>$250.00</td>
<td>$205.0K</td>
<td style="text-align: right;">753</td>
<td style="text-align: right;">222</td>
</tr>
<tr>
<td>WDAY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$15.9</td>
<td>$15.7</td>
<td>$15.87</td>
<td>$250.00</td>
<td>$158.4K</td>
<td style="text-align: right;">753</td>
<td style="text-align: right;">511</td>
</tr>
<tr>
<td>WDAY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$15.9</td>
<td>$15.8</td>
<td>$15.86</td>
<td>$250.00</td>
<td>$156.8K</td>
<td style="text-align: right;">753</td>
<td style="text-align: right;">386</td>
</tr>
</tbody>
</table>
</p>
<h3>About Workday</h3>
<p>Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday is headquartered in Pleasanton, California. Founded in 2005, Workday now employs over 18,000 employees.</p>
<p>Having examined the options trading patterns of Workday, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Current Position of Workday</h3>
<ul>
<li>Currently trading with a volume of 3,612,779, the WDAY's price is up by 0.35%, now at $248.29. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 67 days.</li>
</ul>
<h3>What The Experts Say On Workday</h3>
<p>A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $297.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Goldman Sachs has decided to maintain their Buy rating on Workday, which currently sits at a price target of $305.<br />
&#x2A; Maintaining their stance, an analyst from Keybanc continues to hold a Overweight rating for Workday, targeting a price of $305.<br />
&#x2A; Maintaining their stance, an analyst from Deutsche Bank continues to hold a Hold rating for Workday, targeting a price of $275.<br />
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Workday, which currently sits at a price target of $300.<br />
&#x2A; Maintaining their stance, an analyst from BMO Capital continues to hold a Outperform rating for Workday, targeting a price of $300. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Workday with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


WDAY

Workday's Options: A Look at What the Big Money is Thinking

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

Maxeon Receives Nasdaq Delisting Notification

<p>The Federal Reserve&#8217;s decision cut interest rates by 0.5% on Wednesday <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40943496/fed-rate-cut-eases-debt-refinancing-for-smaller-cloud-computing-firms-analyst-flags">may pull investors</a> away from money market funds and into longer duration bonds, according to a portfolio manager.</p>
<p>Total money market fund assets&nbsp;decreased by $20.02 billion to $6.30 trillion for a week ending on Wednesday, Sept. 18, the Investment Company Institute said. Among taxable money market funds, government funds&nbsp;decreased by $18.82 billion and prime funds decreased by $2.42 billion.&nbsp;</p>
<p>&#8220;Historically, we&#8217;ve seen more assets move into longer duration bonds when yields have fallen, and I think we&#8217;ve already seen some of that happen this year,&#8221; said <strong>Timothy Ng</strong>, a fixed-income portfolio manager with <strong>Capital Group</strong>.</p>
<p>&#8220;I expect this trend to continue as the Fed continues to cut rates,&#8221; he said.</p>
<p><strong>Read Also: <a href="https://www.benzinga.com/real-estate/reit/24/09/40949753/mortgage-rates-near-6-demand-increases-for-refinancing-purchases">Mortgage Rates Near 6%, Demand Increases For Refinancing, Purchases</a></strong></p>
<p>&#8220;I think some of that flow will go into both equities and bonds, but in terms of relative scale, it will likely depend on the outlook for the economy, valuations and market sentiment between the two asset classes.&#8221;</p>
<p>A lot of assets moved into the money markets in recent years because money market yields were very attractive, but that may no longer be the case as the Fed plans to make further rate cuts this year, he said.</p>
<p>&#8220;Now you&#8217;re not getting as much yield waiting around, and you run the risk of missing out on capital appreciation that comes with having more duration in your portfolio as yields fall,&#8221; he said.</p>
<p><strong>Price Action: </strong>Exchange-traded funds that hold money market funds gained slightly into Friday&#8217;s late-afternoon trading.</p>
<ul id="mntl-sc-block_7-0">
<li><strong>iShares Short Treasury Bond ETF</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHV#NASDAQ">SHV</a>) gained 0.05%</li>
<li><strong>BlackRock Short Maturity Bond ETF</strong> (BATS:<a class="ticker" href="https://www.benzinga.com/stock/NEAR#BATS">NEAR</a>) rose 0.06%</li>
<li><strong>SPDR Bloomberg Barclays 1-3 Month T-Bill ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BIL#NYSE">BIL</a>) went up 0.044%</li>
<li><strong>Invesco&nbsp;Ultra Short Duration ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSY#NYSE">GSY</a>) picked up 0.07%</li>
</ul>
<p><strong>Read Now:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/news/24/09/40950904/claudia-sahm-underscores-feds-mandate-to-protect-jobs-says-additional-cuts-expected-the-time-to-supp">Claudia Sahm Underscores Fed&#8217;s Mandate to Protect Jobs, Says Additional Cuts Expected: &#8216;The Time To Support The Labor Market Is When It&#8217;s Strong&#8217;</a></strong></li>
</ul>
<p><em>Photo: Shutterstock</em></p>


Economics

Federal Reserve

ETFs

NEAR

Fed Rate Cut May Drive Investors Away From Money Markets, Says Portfolio Manager

<p>iBio (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IBIO#AMEX">IBIO</a>) reported quarterly losses of $(6.50) per share which beat the analyst consensus estimate of $(7.41) by 12.28 percent.  The company reported quarterly sales of $225.000 thousand which beat the analyst consensus estimate of $25.000 thousand by 800.00 percent.</p>


Earnings Beats

IBIO

iBio FY 2024 GAAP EPS $(6.50) Beats $(7.41) Estimate, Sales $225.000K Beat $25.000K Estimate

<p>Financial giants have made a conspicuous bearish move on CrowdStrike Holdings. Our analysis of options history for CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) revealed 44 unusual trades.</p>
<p>Delving into the details, we found 38% of traders were bullish, while 45% showed bearish tendencies. Out of all the trades we spotted, 12 were puts, with a value of $485,505, and 32 were calls, valued at $1,672,938.</p>
<h3>What's The Price Target?</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $160.0 and $350.0 for CrowdStrike Holdings, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>In today's trading context, the average open interest for options of CrowdStrike Holdings stands at 1009.16, with a total volume reaching 14,198.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in CrowdStrike Holdings, situated within the strike price corridor from $160.0 to $350.0, throughout the last 30 days.</p>
<h3>CrowdStrike Holdings Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726862890_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$5.65</td>
<td>$5.6</td>
<td>$5.6</td>
<td>$310.00</td>
<td>$138.3K</td>
<td>2.9K</td>
<td style="text-align: right;">775</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/27/24</td>
<td>$29.65</td>
<td>$29.25</td>
<td>$29.45</td>
<td>$265.00</td>
<td>$115.0K</td>
<td>512</td>
<td style="text-align: right;">447</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/27/24</td>
<td>$29.65</td>
<td>$29.25</td>
<td>$29.46</td>
<td>$265.00</td>
<td>$94.5K</td>
<td>512</td>
<td style="text-align: right;">447</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$19.1</td>
<td>$18.85</td>
<td>$18.85</td>
<td>$270.00</td>
<td>$94.2K</td>
<td>2.5K</td>
<td style="text-align: right;">301</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/27/24</td>
<td>$29.65</td>
<td>$28.95</td>
<td>$29.37</td>
<td>$265.00</td>
<td>$85.2K</td>
<td>512</td>
<td style="text-align: right;">447</td>
</tr>
</tbody>
</table>
</p>
<h3>About CrowdStrike Holdings</h3>
<p>CrowdStrike is a cloud-based cybersecurity company specializing in next-generation security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform that offers a proverbial single pane of glass for an enterprise to detect and respond to security threats attacking its IT infrastructure. The Texas-based firm was founded in 2011 and went public in 2019.</p>
<p>Following our analysis of the options activities associated with CrowdStrike Holdings, we pivot to a closer look at the company's own performance.</p>
<h3>CrowdStrike Holdings's Current Market Status</h3>
<ul>
<li>Trading volume stands at 9,545,342, with CRWD's price up by 8.03%, positioned at $299.64.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 67 days.</li>
</ul>
<h3>Expert Opinions on CrowdStrike Holdings</h3>
<p>Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $322.4.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Raymond James has decided to maintain their Outperform rating on CrowdStrike Holdings, which currently sits at a price target of $275.<br />
&#x2A; An analyst from Rosenblatt persists with their Buy rating on CrowdStrike Holdings, maintaining a target price of $330.<br />
&#x2A; An analyst from Cantor Fitzgerald has decided to maintain their Overweight rating on CrowdStrike Holdings, which currently sits at a price target of $350.<br />
&#x2A; An analyst from Bernstein has decided to maintain their Outperform rating on CrowdStrike Holdings, which currently sits at a price target of $327.<br />
&#x2A; Maintaining their stance, an analyst from Canaccord Genuity continues to hold a Buy rating for CrowdStrike Holdings, targeting a price of $330. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest CrowdStrike Holdings options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


CRWD

Check Out What Whales Are Doing With CRWD

<p><strong>Nike, Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) is the latest company to take part in what has become a trend among big companies: bringing back an executive to assume <a href="https://www.benzinga.com/news/24/09/40954074/why-nike-shares-are-trading-higher-by-around-7-here-are-20-stocks-moving-premarket">the role of CEO</a>.</p>
<p>The sneaker giant <a href="https://www.benzinga.com/news/24/09/40957353/nikes-new-ceo-elliott-hill-to-focus-on-repairing-retailer-relations">announced on Thursday</a> the appointment of <strong>Elliott Hill</strong>, the company&#8217;s former president of consumer and marketplace who has been with Nike for three decades, as its new CEO to replace retiring CEO <strong>John Donahoe</strong>.</p>
<p>Nike is not alone in having an executive — the company&#8217;s former CEO, in many cases — return to the company to fill its top leadership post in a &#8220;Boomerang CEO&#8221; trend.</p>
<p><strong>Read Also: <a href="https://www.benzinga.com/news/24/04/38209892/nike-stock-jumps-on-upgrade-to-buy-as-analyst-says-its-time-to-just-do-it">Nike Stock Jumps On Upgrade To Buy As Analyst Says It&#8217;s &#8216;Time To Just Do It&#8217;</a></strong></p>
<ul>
<li><strong>Bob Iger</strong>: Almost two years ago, Iger returned to <strong>The Walt Disney Company</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) <a href="https://www.benzinga.com/general/entertainment/22/11/29798775/bob-iger-returns-as-disney-ceo-after-reports-of-growing-rift-with-bob-chapek">as its CEO</a> to replace CEO <strong>Bob Chapek</strong>. Iger previously served in that top role from 2005 to 2020. Last July, the company&#8217;s board voted unanimously to extend his CEO contract to <a href="https://www.benzinga.com/news/23/07/33207650/disneys-board-votes-for-continuity-extends-ceo-igers-contract-to-2026">the end of 2026</a>.</li>
</ul>
<ul>
<li><strong>Howard Schulz</strong>: In April 2022, Schulz returned to <a href="https://www.benzinga.com/news/22/03/26163125/starbucks-ceo-kevin-johnson-announces-retirement-founder-howard-schultz-to-return-in-interim-role">the CEO post</a> at <strong>Starbucks Corporation</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) for the third time in an interim capacity to fill in for retiring CEO<strong> Kevin Johnson</strong>. Schulz founded the company and served as CEO first from 1986 to 2000 and again from 2008 to 2017. He stepped down as interim CEO in August to <a href="https://www.benzinga.com/top-stories/24/08/40396716/starbucks-new-ceo-brian-niccol-boosts-company-valuation-by-over-15b-in-one-day-whats-his-net-worth">hand over the reins</a> to <strong>Brian Niccol</strong>, former CEO of <strong>Chipotle Mexican Grill, Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>).</li>
</ul>
<ul>
<li><strong>Kevin Plank</strong>: At the end of April, Plank<a href="https://www.benzinga.com/markets/equities/24/03/37690723/kevin-plank-returns-as-ceo-under-armours-original-visionary-takes-charge-again"> returned as CEO</a> of <strong>Under Armour, Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UA#NYSE">UA</a>) to replace <strong>Stephanie Linnartz</strong>. He previously served as CEO of the apparel company from 1996, the year he founded it, to 2020.</li>
</ul>
<ul>
<li><strong>Sam Altman</strong>: In November 2023, Altman <a href="https://www.benzinga.com/news/23/11/35911061/sam-altman-to-return-as-openai-ceo-as-new-board-collaborating-to-figure-out-details">returned as the CEO</a> of OpenAI just four days after he was ousted from the position. He was reinstated as CEO on Nov. 22, two days after employees demanded that Altman be given back his CEO job.</li>
</ul>
<ul>
<li><strong>Sergio Ermotti</strong>: In April 2023, Ermotti returned <a href="https://www.benzinga.com/news/large-cap/23/03/31546168/ubs-rehires-former-ceo-to-oversee-credit-suisse-takeover">as the CEO</a> of <strong>UBS Group AG</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBS#NYSE">UBS</a>) to oversee its takeover of Credit Suisse. Ermotti, who assumed the position after CEO Ralph Hamers stepped down, was previously UBS&#8217; CEO from November 2011 to November 2020</li>
</ul>
<p><strong>Price Action:</strong> These companies with returning CEOs saw gains and losses into Friday&#8217;s early-afternoon trading.</p>
<ul>
<li>Nike rose 6.41% to $86.17</li>
<li>Walt Disney gained 0.11% to $93.55</li>
<li>Starbucks dropped 0.64% to $96.28</li>
<li>Under Armour edged up 0.87% to $7.55</li>
<li>UBS slipped 1.43% to $29.97</li>
</ul>
<p><strong>Read Now:</strong></p>
<ul>
<li><strong><a href="http://Bob Iger's Success At Disney: New Document Reveals CEO's Biggest Wins According To The Man Himself">Bob Iger&#8217;s Success At Disney: New Document Reveals CEO&#8217;s Biggest Wins According To The Man Himself</a></strong></li>
</ul>
<p><em>Image: Pixabay</em></p>
<p><a href="https://www.benzinga.com/quote/dis" target="_blank" rel="noreferrer noopener"></a></p>


Entertainment

Success Stories

Tech

SBUX

Nike Executive's Return To Become Top Leader Continues 'Boomerang CEO' Trend At Major Companies

<p>East West Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>) has been analyzed by 11 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts have set 12-month price targets for East West Bancorp, revealing an average target of $94.91, a high estimate of $105.00, and a low estimate of $80.00. This upward trend is evident, with the current average reflecting a 6.26% increase from the previous average price target of $89.32.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726862597_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>The standing of East West Bancorp among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$93.00</td>
<td>$96.00</td>
</tr>
<tr>
<td>Manan Gosalia</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$103.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$96.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Andrew Terrell</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Overweight</td>
<td>$95.00</td>
<td>$86.00</td>
</tr>
<tr>
<td>David Chiaverini</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Outperform</td>
<td>$100.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Timur Braziler</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$95.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Matthew Clark</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$92.00</td>
<td>$72.50</td>
</tr>
<tr>
<td>Gary Tenner</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Buy</td>
<td>$100.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$80.00</td>
<td>$86.00</td>
</tr>
<tr>
<td>Elan Zanger</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$85.00</td>
<td>$94.00</td>
</tr>
<tr>
<td>Jared Shaw</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$105.00</td>
<td>$106.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to East West Bancorp. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of East West Bancorp compared to the broader market.</li>
<li><strong>Price Targets:</strong> Delving into movements, analysts provide estimates for the future value of East West Bancorp's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into East West Bancorp's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/EWBC/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on East West Bancorp analyst ratings.</strong></a></p>
<h2>Unveiling the Story Behind East West Bancorp</h2>
<p>East West Bancorp Inc is the holding company for East West Bank, a full-service commercial bank with cross-border operations concentrated in the United States and China. East-West Bank is one of a few U.S. based banks with a full banking license in China. The bank's cost strategy has increasingly focused on expanding its deposit base away from time deposits to commercial deposits. The bank has also taken part in entertainment partnerships between participants in China and Hollywood. Most of these efforts include financing the production and distribution of film and television projects. The bank leverages its cultural and regulatory knowledge in the U.S. and China to assist its customers in entering new markets. Most of its earning assets are in loans held for investment.</p>
<h3>East West Bancorp: Delving into Financials</h3>
<p><strong>Market Capitalization:</strong> Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.</p>
<p><strong>Revenue Challenges:</strong> East West Bancorp's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately <strong>-1.41%</strong>. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> East West Bancorp's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>46.05%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> East West Bancorp's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>4.05%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> East West Bancorp's ROA excels beyond industry benchmarks, reaching <strong>0.4%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> East West Bancorp's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.5</strong>.</p>
<h2>Analyst Ratings: Simplified</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


EWBC

Navigating 11 Analyst Ratings For East West Bancorp

<p>The Federal Reserve cut interest rates by 50 basis points at its September meeting, lowering the target range to 4.75%-5%. This bold move defied the predictions of most economists who had anticipated a more <a href="https://www.benzinga.com/economics/macro-economic-events/24/09/40927293/powell-defends-0-5-interest-rate-drop-as-right-thing-for-the-economy-doubles-down">modest 25-basis-point reduction.</a></p>
<p>The Fed also hinted at the potential for additional cuts in the coming months, with the updated dot plot revealing a more aggressive rate-cutting trajectory than forecasted in June.</p>
<p>Fed Chair <strong>Jerome Powell</strong> highlighted the labor market as a key focus, stressing the importance of acting preemptively <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40929003/powells-hawkish-tone-tempers-market-excitement-after-historic-50-basis-point-intere">to sustain robust employment</a>. &#8220;The time to support the labor market is when it's strong, not when you begin to see layoffs,&#8221; Powell said.</p>
<p>Powell also called for caution, framing the rate cut as part of a &#8220;recalibration&#8221; rather than a signal of a broader policy shift. He reiterated that future decisions would remain data-dependent, underscoring the Fed's flexibility in responding to economic conditions.</p>
<p>Wall Street analysts reacted by adjusting their rate cut forecasts more aggressively, reflecting expectations of a looser policy trajectory ahead.</p>
<p>Both gold prices and major U.S. stock indices, including the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40941053/s-p-500-dow-jones-hit-record-highs-magnificent-7-add-400-billion-after-feds-histori">S&amp;P 500 and Dow Jones</a>, surged to record highs following the Fed&#8217;s decision.</p>
<h3 class="wp-block-heading">Fed Fuels Growth</h3>
<p>In an exclusive interview with Benzinga, a Lazard small-cap expert highlights the Federal Reserve&#8217;s shift to a pro-growth stance, which is expected to boost Russell 2000's performance. This policy pivot could create favorable conditions for investors in smaller companies, which trade relatively cheaper compared <a href="https://www.benzinga.com/real-estate/reit/24/09/40949753/mortgage-rates-near-6-demand-increases-for-refinancing-purchases">to large-cap counterparts.</a></p>
<h3 class="wp-block-heading">Mortgage Demand Rises</h3>
<p>Mortgage rates fell to near 6%, spurring a surge in demand for both refinancing and home purchases. As homeowners and buyers capitalize on these lower rates, market activity in the real estate sector is picking up momentum, with increased interest in locking <a href="https://www.benzinga.com/real-estate/reit/24/09/40949753/mortgage-rates-near-6-demand-increases-for-refinancing-purchases">in favorable mortgage terms.</a></p>
<h3 class="wp-block-heading">iPhone Demand Lags</h3>
<p>Early pre-order data for <strong>Apple Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>)&#8217;s iPhone 16 suggests weaker-than-expected demand, raising concerns about the device&#8217;s market performance. Ssome analysts believe Apple could still exceed expectations with potential surprises <a href="https://www.benzinga.com/tech/24/09/40930388/apple-iphone-16-pre-orders-show-possible-low-demand-one-sign-could-point-to-company-breaking-this-em">in upcoming earnings reports.</a></p>
<h3 class="wp-block-heading">GM Expands Charging</h3>
<p><strong>General Motors Co.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) has enhanced electric vehicle charging access, opening 17,800 Tesla chargers to all GM drivers via an adapter. This move broadens charging options for GM&#8217;s EV customers, potentially boosting EV adoption and aligning with <a href="https://benzinga.com/markets/equities/24/09/40923696/general-motors-boosts-ev-charging-access-17-800-tesla-chargers-now-open-for-all-gm-drivers-with-">the company&#8217;s electrification goals.</a></p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/24/09/40960886/palantir-dell-to-join-s-p-500-friday-heres-how-tesla-stock-has-performed-since-its-add">Palantir, Dell To Join S&amp;P 500 Friday: Here&#8217;s How Tesla Stock Has Performed Since Its Addition In 2020</a></strong></li>
</ul>


Equities

Large Cap

Macro Economic Events

Broad U.S. Equity ETFs

Econ #s

AAPL

Fed Delivers Large Rate Cut In Bid To Sustain Labor Market; Stocks, Gold Set New Record Highs: This Week In The Markets

<p>In the last three months, 13 analysts have published ratings on Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>), offering a diverse range of perspectives from bullish to bearish.</p>
<p>The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $152.15, a high estimate of $182.00, and a low estimate of $136.00. This current average represents a 2.27% decrease from the previous average price target of $155.69. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726862576_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>The standing of Phillips 66 among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ryan Todd</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$136.00</td>
<td>$151.00</td>
</tr>
<tr>
<td>Connor Lynagh</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$144.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$150.00</td>
<td>$154.00</td>
</tr>
<tr>
<td>Jason Gabelman</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Buy</td>
<td>$150.00</td>
<td>$162.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$182.00</td>
<td>$176.00</td>
</tr>
<tr>
<td>Theresa Chen</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$138.00</td>
<td>$136.00</td>
</tr>
<tr>
<td>Jason Gabelman</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$162.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Justin Jenkins</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$155.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$176.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Paul Cheng</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Outperform</td>
<td>$145.00</td>
<td>$156.00</td>
</tr>
<tr>
<td>Theresa Chen</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$136.00</td>
<td>$142.00</td>
</tr>
<tr>
<td>John Royall</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$162.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Theresa Chen</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$142.00</td>
<td>$147.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Phillips 66. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Phillips 66 compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Phillips 66's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Phillips 66's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/PSX/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Phillips 66 analyst ratings.</strong></a></p>
<h2>Unveiling the Story Behind Phillips 66</h2>
<p>Phillips 66 is an independent refiner with 12 refineries that have a total crude throughput capacity of 1.8 million barrels per day, or mmb/d. In 2023, the Rodeo, California, facility ceased operations and be converted to produce renewable diesel. The midstream segment comprises extensive transportation and NGL processing assets and includes DCP Midstream, which holds 600 mbd of NGL fractionation and 22,000 miles of pipeline. Its CPChem chemical joint venture operates facilities in the United States and the Middle East and primarily produces olefins and polyolefins.</p>
<h3>Key Indicators: Phillips 66's Financial Health</h3>
<p><strong>Market Capitalization:</strong> Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.</p>
<p><strong>Revenue Growth:</strong> Phillips 66 displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately <strong>8.66%</strong>. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Energy sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>2.65%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Phillips 66's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>3.42%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>1.33%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> Phillips 66's debt-to-equity ratio is below the industry average. With a ratio of <b>0.68</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>Analyst Ratings: Simplified</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Phillips 66 Stock: A Deep Dive Into Analyst Perspectives (13 Ratings)

<p>HCA Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) has outperformed the market over the past 10 years by 7.68% on an annualized basis producing an average annual return of 18.9%. Currently, HCA Healthcare has a market capitalization of $104.14 billion. </p>
<p><strong>Buying $100 In HCA:</strong> If an investor had bought $100 of HCA stock 10 years ago, it would be worth <strong>$552.74</strong> today based on a price of $403.52 for HCA at the time of writing.</p>
<h3>HCA Healthcare's Performance Over Last 10 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726862571_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Here's How Much You Would Have Made Owning HCA Healthcare Stock In The Last 10 Years

<p>Molina Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>) has outperformed the market over the past 10 years by 12.09% on an annualized basis producing an average annual return of 23.31%. Currently, Molina Healthcare has a market capitalization of $20.58 billion. </p>
<p><strong>Buying $100 In MOH:</strong> If an investor had bought $100 of MOH stock 10 years ago, it would be worth <strong>$791.70</strong> today based on a price of $351.12 for MOH at the time of writing.</p>
<h3>Molina Healthcare's Performance Over Last 10 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726862566_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Here's How Much You Would Have Made Owning Molina Healthcare Stock In The Last 10 Years

<p>Providing a diverse range of perspectives from bullish to bearish, 16 analysts have published ratings on Chewy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) in the last three months.</p>
<p>The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">10</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $31.06, with a high estimate of $35.00 and a low estimate of $20.00. Marking an increase of 17.34%, the current average surpasses the previous average price target of $26.47. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726862522_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>A clear picture of Chewy's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Peter Keith</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$35.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Seth Basham</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$35.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Doug Anmuth</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$33.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Lauren Schenk</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$33.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Steven Shemesh</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$32.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Trevor Young</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$34.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Michael Lasser</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$30.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Curtis Nagle</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Underperform</td>
<td>$24.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Mark Mahaney</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$29.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Lauren Schenk</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$30.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Justin Kleber</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$32.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Curtis Nagle</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Underperform</td>
<td>$20.00</td>
<td>$18.50</td>
</tr>
<tr>
<td>Seth Basham</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$35.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Steven Zaccone</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$28.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Jonathan Elias</td>
<td>Guggenheim</td>
<td>Raises</td>
<td>Buy</td>
<td>$32.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Seth Basham</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Outperform</td>
<td>$35.00</td>
<td>$28.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Chewy. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Chewy compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
<p>To gain a panoramic view of Chewy's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/CHWY/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Chewy analyst ratings.</strong></a></p>
<h2>All You Need to Know About Chewy</h2>
<p>Chewy is the largest e-commerce pet care retailer in the US, generating $11.2 billion in 2023 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending a couple of years developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods, like crates, leashes, and bowls.</p>
<h3>Understanding the Numbers: Chewy's Finances</h3>
<p><strong>Market Capitalization Highlights:</strong> Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.</p>
<p><strong>Revenue Growth:</strong> Chewy displayed positive results in 3 months. As of 31 July, 2024, the company achieved a solid revenue growth rate of approximately <strong>2.63%</strong>. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>10.46%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Chewy's ROE excels beyond industry benchmarks, reaching <strong>52.96%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Chewy's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>9.49%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> Chewy's debt-to-equity ratio is below the industry average at <strong>1.06</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


CHWY

What 16 Analyst Ratings Have To Say About Chewy

PIXY

ShiftPixy Announces 1-For-15 Reverse Stock Split

<p>During the last three months, 4 analysts shared their evaluations of Insight Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSIT#NASDAQ">NSIT</a>), revealing diverse outlooks from bullish to bearish.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Insights from analysts' 12-month price targets are revealed, presenting an average target of $218.75, a high estimate of $225.00, and a low estimate of $200.00. No alteration is observed as the current average remains at the previous average price target. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726862473_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>The standing of Insight Enterprises among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Vincent Colicchio</td>
<td>Barrington Research</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$225.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Vincent Colicchio</td>
<td>Barrington Research</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$225.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Joseph Cardoso</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$225.00</td>
<td>$233.00</td>
</tr>
<tr>
<td>Matthew Schultheis</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$200.00</td>
<td>$192.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Insight Enterprises. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Insight Enterprises compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Insight Enterprises's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Insight Enterprises's market position. Stay informed and make well-informed decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/NSIT/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Insight Enterprises analyst ratings.</strong></a></p>
<h2>Get to Know Insight Enterprises Better</h2>
<p>Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, governments, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital innovation, cloud/data center transformation, connected workforce, and supply chain optimization solutions and services.</p>
<h3>Key Indicators: Insight Enterprises's Financial Health</h3>
<p><strong>Market Capitalization:</strong> Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Insight Enterprises's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately <strong>-8.0%</strong> in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.</p>
<p><strong>Net Margin:</strong> Insight Enterprises's net margin excels beyond industry benchmarks, reaching <strong>4.05%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Insight Enterprises's ROE excels beyond industry benchmarks, reaching <strong>4.85%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Insight Enterprises's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>1.26%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of <strong>0.66</strong>, caution is advised due to increased financial risk.</p>
<h2>Analyst Ratings: What Are They?</h2>
<p>Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


NSIT

The Analyst Landscape: 4 Takes On Insight Enterprises

<p>5 analysts have expressed a variety of opinions on Independent Bank Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBTX#NASDAQ">IBTX</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.</p>
<p>The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $60.4, a high estimate of $66.00, and a low estimate of $48.00. This current average has increased by 13.53% from the previous average price target of $53.20. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726862455_0.png" alt="price target chart" /></p>
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<p>A clear picture of Independent Bank Gr's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$66.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$65.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Catherine Mealor</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$66.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Catherine Mealor</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$57.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>Brandon King</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$48.00</td>
<td>$50.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Independent Bank Gr. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Independent Bank Gr compared to the broader market.</li>
<li><strong>Price Targets:</strong> Delving into movements, analysts provide estimates for the future value of Independent Bank Gr's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
<p>For valuable insights into Independent Bank Gr's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/IBTX/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Independent Bank Gr analyst ratings.</strong></a></p>
<h2>About Independent Bank Gr</h2>
<p>Independent Bank Group Inc is a bank holding company. It offers services such as checking and savings accounts, debit cards, online banking, including online account opening, mobile banking, eStatements and bank-by-mail and direct deposit services. The Company also offers business accounts and management services, including analyzed business checking, business savings, and treasury management services. The Company derives its income principally from interest earned on loans and, to a lesser extent, income from securities available for sale and securities held to maturity. The Company also derives income from noninterest sources, such as fees received in connection with various deposit services, mortgage banking operations and investment advisory services.</p>
<h3>Independent Bank Gr's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.</p>
<p><strong>Decline in Revenue:</strong> Over the 3 months period, Independent Bank Gr faced challenges, resulting in a decline of approximately <strong>-6.88%</strong> in revenue growth as of 30 June, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> Independent Bank Gr's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>-414.25%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Independent Bank Gr's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>-22.86%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Independent Bank Gr's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>-2.64%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.25</strong>.</p>
<h2>Analyst Ratings: Simplified</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


IBTX

5 Analysts Have This To Say About Independent Bank Gr

<p>18 analysts have shared their evaluations of Corning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts have set 12-month price targets for Corning, revealing an average target of $46.78, a high estimate of $55.00, and a low estimate of $39.00. Surpassing the previous average price target of $42.39, the current average has increased by 10.36%.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726862415_0.png" alt="price target chart" /></p>
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
<p>The perception of Corning by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Martin Yang</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$51.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Wamsi Mohan</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$51.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>Mehdi Hosseini</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Positive</td>
<td>$55.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>John Roberts</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$47.00</td>
<td>$44.00</td>
</tr>
<tr>
<td>Tim Long</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$40.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Martin Yang</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$47.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Mehdi Hosseini</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Positive</td>
<td>$46.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Wamsi Mohan</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$46.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Matthew Niknam</td>
<td>Deutsche Bank</td>
<td>Maintains</td>
<td>Buy</td>
<td>$46.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>Samik Chatterjee</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$55.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Meta Marshall</td>
<td>Morgan Stanley</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$39.00</td>
<td>$39.00</td>
</tr>
<tr>
<td>Asiya Merchant</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$51.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Martin Yang</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$50.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$44.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Matthew Niknam</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Hold</td>
<td>$46.00</td>
<td>$39.00</td>
</tr>
<tr>
<td>Jim Kelleher</td>
<td>Argus Research</td>
<td>Raises</td>
<td>Buy</td>
<td>$50.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Meta Marshall</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$39.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Matthew Niknam</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Hold</td>
<td>$39.00</td>
<td>$35.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Corning. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Corning compared to the broader market.</li>
<li><strong>Price Targets:</strong> Delving into movements, analysts provide estimates for the future value of Corning's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Corning's market position. Stay informed and make well-informed decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/GLW/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Corning analyst ratings.</strong></a></p>
<h2>Get to Know Corning Better</h2>
<p>Corning is a leader in materials science, specializing in the production of glass, ceramics, and optical fiber. The firm supplies its products for a wide range of applications, from flat-panel displays in televisions to gasoline particulate filters in automobiles to optical fiber for broadband access, with a leading share in many of its end markets.</p>
<h3>Key Indicators: Corning's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.</p>
<p><strong>Revenue Growth:</strong> Corning's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately <strong>0.25%</strong>. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Corning's net margin is impressive, surpassing industry averages. With a net margin of <strong>3.2%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Corning's ROE excels beyond industry benchmarks, reaching <strong>0.95%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Corning's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>0.38%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of <strong>0.77</strong>, caution is advised due to increased financial risk.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Unveiling 18 Analyst Insights On Corning

Lifestance Health Group (LFST) has shared an update. Danish Qureshi's tenure as President and COO of LifeStance Health Group ended on June 30, 2024...

LifeStance Health Group Finalizes Executive Separation Terms

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>Investing in low-cost <a href="https://investorplace.com/stock-types/growth-stocks/">growth stocks</a> requires understanding the underlying companies&rsquo; fundamentals. Monitoring the core metrics and operational strengths is vital to assessing a company&rsquo;s long-term viability and growth potential. </p>



<p>Take, for instance, the first company, which&nbsp;shows remarkable improvement in credit performance with a notable reduction in its net charge-off rate. Meanwhile, the second company successfully exceeds its cost reduction targets. It significantly lowered operating expenses and boosted profitability through strategic restructuring. The third company on our list demonstrates exceptional capital management. It uses debt issuance strategically to boost cash flow and navigate market uncertainties. Moreover, the fourth company achieved its first profitability milestone, showcasing effective cost management and operational efficiency.&nbsp;</p>



<p>Similarly, the fifth stock listed here represents a company that significantly reduced production costs, increased operational efficiency and expanded reserves. The sixth company maintained its top position in its field by attaining high top-line growth and improved profitability through sharp cost management and market penetration. Finally, the seventh company demonstrates impressive financial performance and operational improvements.</p>



<p>In short, each of these low-cost growth stocks represents a company with unique fundamentals, making them compelling choices for potential high returns.</p>



<h2>OppFi (OPFI)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/01/creditcards1600-300x169.jpg" alt="a pile of credit cards, credit card interest rates"><div>Source: Teerasak Ladnongkhun/Shutterstock.com</div></div><p><strong>OppFi</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/opfi-stock-quote/"><strong>OPFI</strong></a></span>) specializes in credit performance and financial services. It achieved a&nbsp;<a href="https://s27.q4cdn.com/889956127/files/doc_financials/2024/q1/OppFi-Exceeds-First-Quarter-2024-Guidance-Raises-Full-Year-Earnings-Outlook-2024.pdf" target="_blank">1.1 percentage point&nbsp;</a>improvement in the net charge-off rate, which reduced the rate to 47.9% (in the first quarter),&nbsp;indicating reduced risk and improved credit quality. Effective credit risk management and underwriting processes help maintain financial stability. A&nbsp;<a href="https://s27.q4cdn.com/889956127/files/doc_financials/2024/q1/OppFi-Exceeds-First-Quarter-2024-Guidance-Raises-Full-Year-Earnings-Outlook-2024.pdf" target="_blank">33.5% increase&nbsp;</a>in recoveries further shows improved credit performance. Recovering more from previously charged-off loans mitigates loan defaults&rsquo; impact.</p>



<p>Moreover, early-stage delinquency rates also improved significantly. The first payment default rate decreased by 0.4%. The total&nbsp;<a href="https://finance.yahoo.com/news/oppfi-inc-nyse-opfi-q1-142244972.html" target="_blank">delinquency rate fell by 0.7%</a>&nbsp;compared to last year. These improvements signify stronger credit quality and better customer payment behavior. Lower delinquency rates suggest effective credit risk assessment models. Stronger customer payment behavior supports sustainable revenue and profitability growth.</p>



<p>Finally, OppFi is noted for improved credit quality and risk management, making it a standout in low-cost growth stocks.</p>



<h2>Pitney Bowes (PBI)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/08/pbi-stock-1-300x169.jpg" alt="The office logo for Pitney Bowes on a glass building."><div>Source: JHVEPhoto / Shutterstock.com</div></div><p><strong>Pitney Bowes</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/p%EF%BF%BCbi-stock-quote/"><strong>PBI</strong></a></span>) excels in providing in-office services and supplies and focuses on cost reduction and operational efficiency. The company improved its financial performance significantly. It has exceeded its cost savings target of&nbsp;<a href="https://www.investorrelations.pitneybowes.com/static-files/36e2c1cf-38dc-4a9c-9da3-890a5b116d33" target="_blank">$75 million to $85 million in the first quarter</a>. The restructuring plan&rsquo;s success is evident in cost savings and expense decline. Pitney Bowes now expects to surpass the high end of this target.</p>



<p>Operating expenses dropped 8% year-over-year from a year ago, enhancing financial health. Segment performance shows strong growth potential, with key segments including SendTech, presort services and global e-commerce.</p>



<p>Further, SendTech&rsquo;s earnings before interest and taxes, or EBIT, grew 6% to&nbsp;<a href="https://www.investorrelations.pitneybowes.com/static-files/36e2c1cf-38dc-4a9c-9da3-890a5b116d33" target="_blank">$101 million</a>&nbsp;despite a 2% revenue decline. Shipping-related revenue grew 8%. Software-as-a-service (SaaS) subscription revenue increased by 40%, showing strong growth potential. Presort services achieved record revenue and EBIT. Revenue rose 7% to $170 million, while EBIT&nbsp;<a href="https://www.investorrelations.pitneybowes.com/static-files/df23e5e4-0068-4cb3-a4d9-938d92ccca39" target="_blank">reached $40 million</a>. </p>



<p>Overall, successful restructuring and cost-saving measures position Pitney Bowes as a strong candidate among low-cost growth stocks.</p>



<h2>Garrett Motion (GTX)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/auto1600-300x169.jpg" alt="a front view shot of a white sports car on the highway during daytime"><div>Source: Shutterstock</div></div><p>The technology leader <strong>Garrett Motion </strong>(NASDAQ:<span><a href="https://investorplace.com/stock-quotes/gtx-stock-quote/"><strong>GTX</strong></a></span>) manufactures automotive parts and equipment. Garrett issued&nbsp;<a href="https://investors.garrettmotion.com/node/11641/pdf" target="_blank">$800 million</a>&nbsp;in senior unsecured notes in the second quarter. This move generates annual cash interest savings of $15 million. Reduced debt and interest expenses improve financial stability.</p>



<p>In the second quarter, Garrett repurchased $65 million of common stock. The total repurchased in the first half of 2024 <a href="https://seekingalpha.com/article/4706607-garrett-motion-inc-gtx-q2-2024-earnings-call-transcript" target="_blank">reached $174 million</a>. This strategy signals confidence in future growth prospects. The company ended the quarter with&nbsp;solid&nbsp;liquidity of $698 million. This&nbsp;includes $600 million of undrawn revolving credit and $98 million of unrestricted cash.</p>



<p>Additionally, Garrett has ample financial flexibility for economic uncertainties and growth opportunities. Its strength is adapting its cost structure to industry volatility. Garrett offset reduced sales through operational productivity and cost control. The adjusted EBITDA margin remained&nbsp;<a href="https://investors.garrettmotion.com/node/11641/pdf" target="_blank">resilient at 16.9%</a>&nbsp;despite a 12% drop in net sales.</p>



<p>In summary, effective capital management and share repurchase strategies enhance its appeal, making it a top pick among low-cost growth stocks.</p>



<h2>Tuniu (TOUR)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/06/travel-stocks-1600-300x169.jpg" alt="A photo of an excited woman riding on the back of a bike a man is driving."><div>Source: OPOLJA / Shutterstock.com</div></div><p>The online leisure travel company <strong>Tuniu</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/tour-stock-quote/"><strong>TOUR</strong></a></span>) is based in China provides hospitality services, including hotels, resorts, and cruise lines. Tuniu achieved GAAP profitability in the first quarter. The company reported net income of&nbsp;<a href="https://filecache.investorroom.com/mr5ir_tuniu/202/Tuniu%20Announces%20Unaudited%20First%20Quarter%202024%20Financial%20Results.pdf" target="_blank">RMB 22 million</a> ($3.03 million),&nbsp;which marks a significant milestone for Tuniu. Last year, the company had a loss of RMB 5.9 million.</p>



<p>Operating expenses increased by&nbsp;<a href="https://filecache.investorroom.com/mr5ir_tuniu/202/Tuniu%20Announces%20Unaudited%20First%20Quarter%202024%20Financial%20Results.pdf" target="_blank">25% from a year ago to RMB 69.7 million</a>. The proportion of operating expenses relative to net revenues decreased significantly.&nbsp;</p>



<p>Moreover, total operating expenses as a percentage of net revenues dropped by 20 percentage points. Indeed, this decline indicates improved operational efficiency. Research expenses decreased by 9% to RMB 13 million. Research and development costs as a percentage of net revenues dropped from&nbsp;<a href="https://finance.yahoo.com/news/tuniu-corporation-nasdaq-tour-q1-120241361.html" target="_blank">22.7% to 12.1%</a>, indicating Tuniu&rsquo;s efficient resource allocation. The company&rsquo;s cost-control measures in research are effective.</p>



<p>Finally, Tuniu&rsquo;s recent profitability and improved efficiency contribute to its selection on the low-cost growth stocks list.</p>



<h2>Nexa Resources (NEXA)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/02/precious-metals-1600-300x169.jpg" alt="Close-up of a gold-ingot on top of a troy ounce silver and palladium bar. Precious metals. Gold, silver, palladium. materials stocks. resource shortage stocks"><div>Source: corlaffra / Shutterstock</div></div><p><strong>Nexa Resources</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/nexa-stock-quote/"><strong>NEXA</strong></a></span>) is a diversified metals and mining company in Brazil. In the first quarter, metal sales totaled&nbsp;<a href="https://www.nexaresources.com/en/nexa-resources-delivers-solid-operating-performance-in-1q24/" target="_blank">139,000 metric tons</a>. This&nbsp;marked a 4% year-over-year decline, caused by lower production volumes and seasonal demand. Additionally, the cost of smelting cash fell to 98 cents per pound, a 22% decrease from $1.25 per pound a year ago. Lower raw material costs and decreased zinc prices drove this reduction. Conversion costs were&nbsp;<a href="https://finance.yahoo.com/news/nexa-resources-nyse-nexa-q1-142029857.html" target="_blank">30 cents per pound</a>, down from 31 cents a year ago. Hence, lower variable and energy costs contributed to this decrease.&nbsp;</p>



<p>Further, capacity utilization for the company&rsquo;s Aripuan&atilde;&rsquo;s mine increased to&nbsp;<a href="https://finance.yahoo.com/news/nexa-resources-nyse-nexa-q1-142029857.html" target="_blank">70% in April&nbsp;</a>from 57% in Q1 2024. Zinc recovery improved to 73% in March from 66% in December 2023. The company&rsquo;s Cerro de Pasco project has a sharp 59% increase in mineral reserves.</p>



<p>Nexa&rsquo;s overall mineral reserves grew 10% in 2023 against 2022. Moreover, progressive exploration and drilling activities boosted reserves. In short, improved cost efficiencies and enhanced production make Nexa a top pick among low-cost growth stocks.</p>



<h2>High Tide (HITI)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/02/medical-marijuana-cannabis-300x169.png" alt="An image of different forms of medical marijuana"><div>Source: Bukhta Yurii/Shutterstock</div></div><p><strong>High Tide</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/hiti-stock-quote/"><strong>HITI</strong></a></span>) is a Canadian cannabis company that operates in the pharmaceuticals sector, focusing on drug development and distribution. In the second quarter, High Tide recorded <a href="https://hightideinc.com/high-tide-reports-second-quarter-2024-financial-results-featuring-record-free-cash-flow-of-9-4-million-and-positive-net-income/" target="_blank">$124.3 million in revenue</a>, marking a 5% increase from a year ago. The company surpassed $500 million in trailing 12-month revenue. With that, High Tide, Canada&rsquo;s highest revenue-generating cannabis company, maintained this lead for almost two years.</p>



<p>Additionally, the company&rsquo;s core brick-and-mortar segment grew by 11% from a year ago, accounting for 93% of the company&rsquo;s&nbsp;top line.&nbsp;This outperforms peers, who&nbsp;<a href="https://seekingalpha.com/article/4699347-high-tide-inc-hiti-q2-2024-earnings-call-transcript" target="_blank">average $923,000</a>.</p>



<p>High Tide&rsquo;s average Ontario store had a $3.4 million annual revenue&nbsp;run rate. The gross profit for the quarter was $35.3 million (up 12% from year ago. The gross profit margin improved to 28.4%, which was the highest in nine quarters.</p>



<p>Indeed, High Tide&rsquo;s financial stability and cost management highlight its growth potential, standing out in the low-cost growth stocks category.</p>



<h2>Lifestance Health (LFST)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/09/telehealth_1600_b-300x169.jpg" alt="A woman talks to a doctor on her laptop. telehealth stocks"><div>Source: fizkes/ShutterStock.com</div></div><p><strong>Lifestance Health</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/lfst-stock-quote/"><strong>LFST</strong></a></span>) offers mental health services in a telemedicine format. The company&rsquo;s bottom line&nbsp;is solid. Adjusted EBITDA for&nbsp;the first quarter <a href="https://investor.lifestance.com/node/9066/pdf" target="_blank">was $27.7 million</a>, a massive 174% increase from the previous year&rsquo;s $10.1 million. The adjusted EBITDA margin improved to 9.2%, up from 4% in Q1 2023. This growth is due to higher revenue per visit. Enhanced operating leverage also played a key role.</p>



<p>Moreover, the company scaled efficiently while controlling costs. LifeStance achieved a 36% increase in center margin, which reached $94.7 million, or 31.5% of total revenue. The center margin as a percentage of revenue grew nearly <a href="https://investor.lifestance.com/node/9066/pdf">4 percentage points</a> year over year,&nbsp;reflecting effective cost management and operational efficiencies.&nbsp;</p>



<p>Indeed, the increase in the center margin indicates improved profitability. Real estate optimization and operating leverage drove this improvement. Efficiently managing center costs and&nbsp;<a href="https://investor.lifestance.com/static-files/53934f14-4039-478b-a556-319fc5e966e8" target="_blank">higher revenue per visit&nbsp;</a>contributed to this success. LifeStance has shown it can scale operations profitably. Strong financial performance and operational improvements make it a top pick among low-cost growth stocks.</p>



<p><em><strong>On Penny Stocks and Low-Volume Stocks:</strong>&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.</em></p>



<p><em><strong>Read More:</strong>&#8239;Penny Stocks &mdash;&nbsp;</em><a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank"><em>How to Profit Without Getting Scammed</em></a></p>



<p><em>On the date of publication, Yiannis Zourmpanos did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines.</a></em></p>



<p><em>On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.</em></p>
<div><p>Yiannis Zourmpanos is the founder of Yiazou Capital Research, a stock-market research platform designed to elevate the due diligence process through in-depth business analysis.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>
<p>The post <a href="https://investorplace.com/2024/08/7-low-cost-stocks-with-unexpected-growth-potential/">7 Low-Cost Stocks With Unexpected Growth Potential</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

7 Low-Cost Stocks With Unexpected Growth Potential

LifeStance Health Group GAAP EPS of -$0.06, revenue of $312.3M

Goldman Sachs analyst Jamie Perse has maintained their bullish stance on LFST stock, giving a Buy rating on July 23. Jamie Perse has given his Buy ...

Robust Growth and Strong Financials Drive Buy Rating for Lifestance Health Group

LifeStance Health Group, Inc. 2024 Q2 - Results - Earnings Call Presentation

LifeStance Health Group, Inc. (LFST) Q2 2024 Earnings Call Transcript

Barclays analyst Stephanie Davis maintained a Sell rating on Lifestance Health Group (LFST – Research Report) today and set a price target of $6.00...

Barclays Sticks to Their Sell Rating for Lifestance Health Group (LFST)

Morgan Stanley's 20 Top Stock Picks

LifeStance Health Group: Long-Term Growth With Adj. EBITDA Margin Inflection Upwards

In a report released today, Craig Hettenbach from Morgan Stanley maintained a Buy rating on Lifestance Health Group (LFST – Research Report), with ...

Lifestance Health Group: A Strong Buy on Accessible Mental Healthcare and Market Positioning

CMCSA

DKNG

FTAI

HITI

NDAQ

NEXA

NTRA

NVDA

OPFI

SPOT

TOST

TOUR

TSLA

Press Releases

LifeStance Destigmatizes Mental Health in Newest "Not One Face" Campaign Featuring Photography from Leica Ambassadors

LifeStance Reports First Quarter 2024 Results

LifeStance Health Group Announces Launch of Secondary Public Offering

IPOs

LifeStance Health Group Announces Pricing of Secondary Public Offering

LifeStance to Participate in Upcoming Investor Conferences

LifeStance to Host Second Quarter 2024 Earnings Conference Call on August 8, 2024

LifeStance Survey Finds US Adults Prioritize Access to Therapy Over Free Taylor Swift Tickets and Vacations

LifeStance Reports Second Quarter 2024 Results

Legal

Bragar Eagel & Squire, P.C. Is Investigating LifeStance and Customers Bancorp and Encourages Investors to Contact the Firm

LifeStance to Present at the 22nd Annual Morgan Stanley Healthcare Conference

CUBI

Addus HomeCare Corporation - Common Stock

Addus HomeCare

Agilon Health

Amedisys

AMN Healthcare Services

Astrana Health

BrightSpring Health Services, Inc. - Common Stock

BrightSpring Health

Chemed

Cigna

CorVel

CVS Health

Quest Diagnostics Incorporated Common Stock

Quest Diagnostics

DaVita

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

LifeStance Health Gr

LifeStance Health Gr (LFST) Forecast

LifeStance Health Gr (NASDAQ:LFST) Stock, Quote.Headers.trade-ideas